Is it feasible to identify preterm infants with respiratory distress syndrome for early extubation to continuous positive airway pressure post‐surfactant treatment during retrieval?

Abstract

FiO2 on stabilisation post-surfactant treatment has a weak predictive value and may not be adequate to be used as sole criteria to extubate to CPAP prior to transport. FiO2 at stabilisation should be included as an eligibility criteria for a randomised trial of INSURE during retrieval, but other clinical assessments are needed.

Effects of underwater bubble CPAP on very-low-birth-weight preterm newborns in the delivery room and after transport to the neonatal intensive care unit

“…The effectiveness, lower cost, and ease of use of the ubCPAP system are corroborated by other studies that note its use in regions with limited financial resources (Arca et al, 2015; Bohlin, 2012; McAdams et al, 2015). Training a multidisciplinary team is fundamental to optimizing task execution in the delivery room when treating VLBW preterm newborns and to safely implement all of the steps recommended in the literature (Aly et al, 2004; Priyadarshi et al, 2015).…”

“…This provides adequate ventilatory support to counteract the biomechanical and physiological difficulties in breathing in preterm newborns (Guinsburg and Almeida, 2016; Wyllie et al, 2015). As suggested by several studies, the use of CPAP improves the survival rates of infants, decreasing the need for intubation without increasing mortality (Hascoet et al, 2008; Martin et al, 2014; Priyadarshi et al, 2015).…”